Described herein are sulfonium compounds that are agonists (e.g., silent or partial) of the mammalian α7 or α9 nicotinic acetylcholine receptors. Further provided are pharmaceutical compositions that allow the administration of the sulfonium compounds to a subject in need of treatment for a pathological condition arising from such as inflammation.
Sulfonium compounds and methods for making and using the same / R.L. Papke, C. Dallanoce, C. Papotto.
Sulfonium compounds and methods for making and using the same
C. Dallanoce;C. Papotto
2024
Abstract
Described herein are sulfonium compounds that are agonists (e.g., silent or partial) of the mammalian α7 or α9 nicotinic acetylcholine receptors. Further provided are pharmaceutical compositions that allow the administration of the sulfonium compounds to a subject in need of treatment for a pathological condition arising from such as inflammation.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
